Clinical Trial Update: Mirabegron For Erectile Dysfunction [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating mirabegron for erectile dysfunction has completed, with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction
• Overactive Bladder
• Urinary Incontinence

Drugs mentioned

• Mirabegron (mirabegron)

Snippet

Sponsor: Johns Hopkins University | Conditions: Erectile Dysfunction, Overactive Bladder | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-01-05